内部人交易雷达

美国 · SEC Form 4 · 快照日期: 2026-10-18 · 构建时间: 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

Chemomab Therapeutics Ltd.

CMMB · Nasdaq · CIK 0001534248 · Healthcare · Biotechnology

内部人信号

29.8 / 100

1 位买方 · 2 条买入交易行 · $20.2K 买入总额

为什么有这个信号?

买方广度较低
买入规模较低
角色中等
近期性较低
确信度中等
评分构成

每条进度条表示其对当前分数的贡献;权重和公式保持不变。

Cluster+7.0 / 35
买入规模+2.1 / 25
角色+13.0 / 20
近期性+0.9 / 10
确信度+6.8 / 10

哪些因素限制了当前分数?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ 角色得分低 · 买入者中职位最高的是:Chief Executive Officer(CEO、董事长和持股 10% 以上的股东得分最低)
  • ⚠ Purchase activity is becoming less recent
  • ⚠ Buying conviction is reduced by concurrent selling

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后,不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。

AprMayJunJulAugSepOct
Mor George AdiChief Executive Officer
○●
Cohen Neil HarrisDirector
▼▼
● 买入▼ 卖出○ 其他

—

买方广度与集中度

合资格买方1
买入集中度100%最大买方: Mor George Adi · $20.2K
聚集买入 · 15天1 insider峰值活动: 2026-05-29–2026-05-29

Roles in the peak window: Chief Executive Officer. Concentration uses priced qualifying P lines only and does not change the saved score.

信号历史

29.8 / 100

最新留档分数

→ +0.0 pts相对上一个留档快照
  1. 29.9
  2. 29.9
  3. 29.9
  4. 29.8
  5. 29.8

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

2买入
2卖出
2其他 Form 4 交易行
2SEC 申报 · 365天
买入2 qualifying P line(s) · 180 days
卖出2 sale line(s) · 仅供背景
其他2 exercise / withholding / award / gift / other lines
10b5-1/计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息,不影响内部人信号。

价格表现

1M
-46.9%
3M
-16.4%
6M
-17.4%
12M
-60.6%

波动率与流动性

波动率
86.9%
Beta
—
平均每日成交额
USD 150,709

估值

市值
—
P/E
—

基本面

利润率
—
ROE
-72.9%
细分行业
Biotechnology

市场数据

价格数据截至:2026-10-11 · 价格来源:OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件:ROE · 财年截止日:2025-12-31 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。

空头股数
10,544
上期报告
81,947
日均成交量
215,472
回补天数
≤ 1.0

FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-05-29Mor George Adi买入 (P)American Depositary Shares9,804USD 2.07USD 20,246SEC 申报 ↗
2022-05-24Maryles Joel Michael买入 (P)American Depositary Shares433USD 2.88USD 1,247SEC 申报 ↗
2022-05-18Cohen Neil Harris买入 (P)American Depositary Shares2,000USD 3.19USD 6,380SEC 申报 ↗
2022-03-18Maryles Joel Michael买入 (P)American Depositary Shares1,000USD 4.34USD 4,340SEC 申报 ↗
2022-03-16Marvin Donald买入 (P)American Depositary Shares500USD 3.27USD 1,638SEC 申报 ↗
2022-03-14Marvin Donald买入 (P)American Depositary Shares1,250USD 4.04USD 5,045SEC 申报 ↗
2022-03-14Pfost Dale R买入 (P)American Depositary Shares2,500USD 3.98USD 9,943SEC 申报 ↗
2022-03-14Cohen Neil Harris买入 (P)American Depositary Shares6,000USD 4.35USD 26,120SEC 申报 ↗
2022-03-11Darvish Nissim买入 (P)American Depositary Shares1,200USD 4.28USD 5,136SEC 申报 ↗
2021-12-06Cohen Neil Harris买入 (P)American Depositary Shares2,000USD 7.43USD 14,860SEC 申报 ↗
2021-03-16Cohen Neil Harris买入 (P)American Depositary Shares2,409USD 41.51USD 99,998SEC 申报 ↗
2021-03-16THIEL PETER买入 (P)American Depositary Shares230,536USD —USD —SEC 申报 ↗

Form 4 申报证据

6 transaction lines in the latest 365-day window; 35 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-08-28Cohen Neil Harris卖出 (S)American Depositary Shares1,000USD 2.80USD 2,800SEC 申报 ↗
2026-08-27Cohen Neil Harris卖出 (S)American Depositary Shares1,304USD 2.85USD 3,716SEC 申报 ↗
2026-05-29Mor George Adi买入 (P)American Depositary Shares9,804USD 2.07USD 20,246SEC 申报 ↗
展开近期 Form 4 证据 (4 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-08-28Cohen Neil Harris卖出 (S)American Depositary Shares1,000USD 2.80USD 2,800SEC 申报 ↗
2026-08-27Cohen Neil Harris卖出 (S)American Depositary Shares1,304USD 2.85USD 3,716SEC 申报 ↗
2026-05-29Mor George Adi买入 (P)American Depositary Shares9,804USD 2.07USD 20,246SEC 申报 ↗
2026-05-29Mor George AdiJ (J)American Depositary Shares50,462USD —USD —SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码CMMB
CIK0001534248
行业Healthcare
细分行业Biotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
交易所Nasdaq

数据覆盖

本地 Form 4 历史35 transaction lines from 2021-03-16 to 2026-08-28
23 P purchase lines · 9 S sale lines · 3 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.